Truqap is a kinase inhibitor that works by blocking pathways that help the most cancers cells endure and improve, so cuts down cancer growth. Truqap is from a category of medicines called an AKT inhibitor. Truqap received FDA approval on November seventeen, 2023, just after positive results in the CAPItello-291 https://milovann887bmx9.blogproducer.com/profile